Forbes

Gene Therapy Stocks Continue To Underperform. Are They Worth A Look?

Gene Therapy Stocks Continue To Underperform. Are They Worth A Look?

Gene therapy – which aims to treat diseases by essentially inserting a gene into a patient’s cells rather than via drugs or surgery – was a hot trend in the biotech space, but investor interest in the sector appears to have died down considerably, on account of high R&D spending and delays…

Source: Forbes – Markets
Date: September 30, 2020, 22:55